Cabot (NYSE:CBT) Stock Rating Lowered by Mizuho

Cabot (NYSE:CBT) was downgraded by investment analysts at Mizuho from a “strong-buy” rating to a “hold” rating in a report released on Wednesday,Zacks.com reports.

Other analysts have also recently issued reports about the company. JPMorgan Chase & Co. cut their price objective on Cabot from $75.00 to $54.00 and set an “underweight” rating for the company in a research report on Friday, November 28th. Zacks Research upgraded Cabot from a “strong sell” rating to a “hold” rating in a research note on Tuesday, January 27th. UBS Group lifted their price objective on shares of Cabot from $74.00 to $81.00 and gave the stock a “neutral” rating in a research report on Thursday. Jefferies Financial Group reiterated a “buy” rating and issued a $85.00 price objective on shares of Cabot in a report on Wednesday. Finally, Weiss Ratings restated a “hold (c-)” rating on shares of Cabot in a research note on Monday, December 29th. One investment analyst has rated the stock with a Buy rating, four have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $73.75.

Cabot Stock Performance

Shares of CBT opened at $76.39 on Wednesday. The company has a market cap of $4.04 billion, a PE ratio of 13.38, a price-to-earnings-growth ratio of 4.12 and a beta of 0.88. The firm has a 50-day moving average of $69.04 and a 200-day moving average of $71.69. Cabot has a one year low of $58.33 and a one year high of $89.15. The company has a debt-to-equity ratio of 0.49, a current ratio of 1.67 and a quick ratio of 1.08.

Cabot (NYSE:CBT) last issued its earnings results on Tuesday, February 3rd. The specialty chemicals company reported $1.53 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.40 by $0.13. Cabot had a net margin of 8.62% and a return on equity of 22.81%. The company had revenue of $849.00 million for the quarter, compared to analysts’ expectations of $889.11 million. During the same period in the prior year, the firm earned $1.76 EPS. Cabot’s quarterly revenue was down 11.1% compared to the same quarter last year. Cabot has set its FY 2026 guidance at 6.000-6.500 EPS. As a group, equities analysts forecast that Cabot will post 7.57 earnings per share for the current year.

Hedge Funds Weigh In On Cabot

Hedge funds have recently bought and sold shares of the business. Torren Management LLC bought a new stake in Cabot in the 4th quarter valued at about $26,000. Smartleaf Asset Management LLC raised its position in shares of Cabot by 598.0% in the third quarter. Smartleaf Asset Management LLC now owns 349 shares of the specialty chemicals company’s stock valued at $27,000 after buying an additional 299 shares in the last quarter. Elevation Point Wealth Partners LLC bought a new stake in shares of Cabot in the second quarter valued at approximately $28,000. Parkside Financial Bank & Trust boosted its stake in shares of Cabot by 95.5% in the second quarter. Parkside Financial Bank & Trust now owns 387 shares of the specialty chemicals company’s stock valued at $29,000 after buying an additional 189 shares during the period. Finally, Hantz Financial Services Inc. grew its position in Cabot by 227.5% during the third quarter. Hantz Financial Services Inc. now owns 429 shares of the specialty chemicals company’s stock worth $33,000 after buying an additional 298 shares in the last quarter. 93.18% of the stock is owned by institutional investors.

Cabot Company Profile

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.